Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP450033.RAEDWjVg_l0pgIZjKEp4pJhuPPEOUnsBGHv8b37gOqRx0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP450033.RAEDWjVg_l0pgIZjKEp4pJhuPPEOUnsBGHv8b37gOqRx0130_assertion type Assertion NP450033.RAEDWjVg_l0pgIZjKEp4pJhuPPEOUnsBGHv8b37gOqRx0130_head.
- NP450033.RAEDWjVg_l0pgIZjKEp4pJhuPPEOUnsBGHv8b37gOqRx0130_assertion wasGeneratedBy ECO_0000203 NP450033.RAEDWjVg_l0pgIZjKEp4pJhuPPEOUnsBGHv8b37gOqRx0130_provenance.
- NP450033.RAEDWjVg_l0pgIZjKEp4pJhuPPEOUnsBGHv8b37gOqRx0130_assertion wasDerivedFrom befree-20150227 NP450033.RAEDWjVg_l0pgIZjKEp4pJhuPPEOUnsBGHv8b37gOqRx0130_provenance.
- NP450033.RAEDWjVg_l0pgIZjKEp4pJhuPPEOUnsBGHv8b37gOqRx0130_assertion SIO_000772 20140681 NP450033.RAEDWjVg_l0pgIZjKEp4pJhuPPEOUnsBGHv8b37gOqRx0130_provenance.
- NP450033.RAEDWjVg_l0pgIZjKEp4pJhuPPEOUnsBGHv8b37gOqRx0130_assertion evidence source_evidence_literature NP450033.RAEDWjVg_l0pgIZjKEp4pJhuPPEOUnsBGHv8b37gOqRx0130_provenance.
- NP450033.RAEDWjVg_l0pgIZjKEp4pJhuPPEOUnsBGHv8b37gOqRx0130_assertion description "[Further investigation of HIF-1 alpha inhibition for anti-tumor activity is warranted and may potentially prove HIF-1 alpha as a therapeutic target in the management ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450033.RAEDWjVg_l0pgIZjKEp4pJhuPPEOUnsBGHv8b37gOqRx0130_provenance.